This is a re-scheduled webinar originally scheduled for May 23rd.

Medications, specifically methadone and buprenorphine, are the gold standard for treatment of opioid use disorder. They are associated with significant reductions in fatal overdose, and they're extremely cost-effective medications. Come learn about the growing body of evidence for MOUD with a particular focus on MOUD in jails!

Learning Objectives:

1. Learners will able to describe the financial costs and benefits of medications for opioid use disorder in both outpatient and carceral settings
2. Describe the nonfinancial benefits of such medications in both settings.

JK Costello, MD, MPH, is the director of behavioral health consulting for the Steadman Group. He has developed population health plans for substance use disorder prevention, treatment and recovery. Inspired by the ongoing explosion of addiction and overdose, he works across medicine, public health, and community organizations to create a community of recovery in publicly-funded treatment systems.